| TaiGen Biotechnology Co., Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110178107 | HCV PROTEASE INHIBITORS - This invention relates to compounds of Formula (I), (II), or (III) shown in the specification. These compounds can be used to treat hepatitis C virus infection. | 07-21-2011 |
| 20110065737 | HCV PROTEASE INHIBITORS - This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection. | 03-17-2011 |
| 20100152452 | STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES - This invention relates to dialdehyde or dinitrile compounds, which are useful for stereoselective synthesis of piperidine, pyrrolidine, and azepane derivatives. | 06-17-2010 |
| 20100120719 | LYOPHILIZATION FORMULATION - This invention relates to a pharmaceutical kit containing a lyophilized preparation of a pyrimidine compound described in the specification. Also disclosed is a lyophilization process for making this preparation. | 05-13-2010 |
| 20100041697 | PNEUMONIA TREATMENT - This invention relates to a method of treating pneumonia by orally administering to a subject in need thereof a quinolone compound of formula (I), shown in the disclosure, at a daily dose of 2-30 mg/kg. | 02-18-2010 |
| 20100004282 | TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA INFECTION - This invention relates to a method of treating infection by methicillin-nonsusceptibale bacteria, vancomycin-nonsusceptibale bacteria, penicillin-nonsusceptibale bacteria, clarithromycin-nonsusceptibale bacteria, or metronidazole-nonsusceptibale bacteria by administering to a subject in need thereof an effective amount of a compound of the following formula: | 01-07-2010 |
| 20090286814 | HCV PROTEASE INHIBITORS - This invention relates to macrocyclic compounds of formula (I) or (II) shown in the specification. These compounds can be used to treat hepatitis C virus infection. | 11-19-2009 |
| 20090264339 | Heterocyclic Compounds - This invention relates to heterocyclic compounds of the formulas shown in the specification. It also relates to methods for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, and tissue injuries with one of the heterocyclic compounds. | 10-22-2009 |
| 20090214529 | KINESIN INHIBITORS - This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat a kinesin Eg5 protein-mediated disorder. | 08-27-2009 |
| 20090143302 | PYRIMIDINE COMPOUNDS - This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification. | 06-04-2009 |
| 20090111757 | HCV PROTEASE INHIBITORS - Compounds of formula (I): | 04-30-2009 |
| 20080292626 | KINESIN INHIBITORS - This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat a kinesin Eg5 protein-mediated disorder. | 11-27-2008 |
